Anabolic Steroids Market size was valued at USD 16.42 billion in 2024 and is set to exceed USD 55.36 billion by 2037, registering over 9.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of anabolic steroids is evaluated at USD 17.71 billion.. As the number of elderly people increases, so does the market for anabolic steroids. People 60 years of age and older will outnumber children under five by 2023.Eighty percent of the elderly worldwide will reside in low- and middle-income nations by 2050. The rate of population aging is far faster than it used to be. Furthermore, the anabolic steroids market is expanding as men's weight issues get worse.
In addition to these, the list of uses for androgens and anabolic steroids may grow in the future. Their potential application in the management of a number of illnesses, including osteoporosis, disorders involving the breakdown of muscle, and several hormone imbalances, is still being investigated. Furthermore, creating new, practical delivery methods for androgens and anabolic steroids like long-acting injectables or transdermal patches can enhance patient compliance and the therapy process as a whole.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
9.8% |
Base Year Market Size (2024) |
USD 16.42 billion |
Forecast Year Market Size (2037) |
USD 55.36 billion |
Regional Scope |
|
Modes of Administration (Oral, Injection, Topical, Skin Patches, Inhalers)
Based modes of administration, injection segment in the anabolic steroids market is anticipated to hold 45% of the revenue share by 2037. The injections segment is being driven by a number of factors, including high unmet demand, an increase in the frequency of bone & joint problems, government awareness programs for joint disorders, a rise in the number of obese people as a result of unhealthy lifestyles, and favorable health insurance coverage. Globally, the Statistic Brain Research Institute estimates that 50 million people have been diagnosed with arthritis. The global market for steroid injections is also being driven by factors such as growing demand for steroid injections, improvements in steroid injection treatment, and growing health consciousness. About 180 million people in India suffer from arthritis, according to Arthritis-India. The prevalence of many well-known illnesses is higher than this, including cancer, AIDS, and diabetes. With more than 60 million people predicted to be impacted, India is predicted to become the global epicenter for osteoarthritis by 2025. Owing to the quick and efficient results, there is a growing demand for steroid injections, which is driving this anabolic steroids market expansion.
Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Based on distribution channels, online pharmacies segment in the anabolic steroids market is anticipated to hold 40% of the revenue share by 2037. Online sales are expected to rise since manufacturers and distributors are currently leaning toward doing business online. Furthermore, the anabolic steroids market is driven higher by the growing usage of smartphones and the widespread use of social media. Global mobile user count was 7.1 billion in 2021; predictions indicate that by 2022, this figure is expected to increase to 7.26 billion. Global mobile user count is expected to reach 7.49 billion by 2025.
Our in-depth analysis of the global market includes the following segments:
Synthetic Derivatives |
|
Modes of Administration |
|
Indication |
|
Drugs |
|
Type |
|
Applications |
|
Distribution Channels |
|
North American Market Forecast
Anabolic steroids market in North America region is attributed to hold largest revenue share of about 33% during the forecast period. The market for anabolic steroids is anticipated to be dominated by North America due to the region's increasing incidence of breast cancer and increased healthcare spending, which will also accelerate the market's growth pace. There will be roughly 310,720 new instances of invasive breast cancer detected in females. There will be roughly 56,500 new diagnoses of ductal carcinoma in situ (DCIS). There will be 42,250 female breast cancer deaths. Moreover, the anabolic steroids market growth rate in this region will also be accelerated by the expanding presence of significant key players and the increased use of innovative technologies.
APAC Market Statistics
Anabolic steroids market in Asia Pacific region is projected to hold second largest revenue share of about 30% during the forecast period. The region's rising level of disposable income is the reason behind the expansion of the anabolic steroid business there. Additionally, the expansion of the healthcare sector and the growing number of generic medicine manufacturers will accelerate the growth rate of this industry. In 2018, more than 90% of the Indian pharmaceutical industry was made up of generic medications. In contrast, generics made up just about 29% of the Taiwanese pharmaceutical industry that year.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?